Granisetron Hydrochloride 0.2-mg/mL Oral Suspension
Download in electronic PDF format for $65
Abstract: A formulation for preparing Granisetron Hydrochloride 0.2-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords:
Loyd V. Allen Jr., PhD, RPh, formulation, granisetron hydrochloride, selective type 3 serotonergic blocker, 5-HT3 receptor antagonist, serotonin receptor inhibitor, antiemetic agent, postoperative nausea, vomiting, cancer chemotherapy
Related Categories:
CANCER AND AIDS, FORMULATIONS, GASTROENTEROLOGY, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 419
|
Granisetron 1-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 66
|
Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 513
|
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride
Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
|
Jan/Feb 2018
Pg. 86-94
|
Granisetron 0.05-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 222
|
Basics of Compounding for the Treatment of Warts
Allen Loyd V Jr
|
Mar/Apr 2004
Pg. 126-129
|
Ondansetron Hydrochloride 2-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 339
|
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride
Wu George, Yeung Stanley, Chen Frank
|
Jan/Feb 2017
Pg. 76-82
|
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
|
Mar/Apr 2008
Pg. 156-160
|
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|